Published in

Elsevier, Lung Cancer, (165), p. 71-81, 2022

DOI: 10.1016/j.lungcan.2021.12.009

Links

Tools

Export citation

Search in Google Scholar

Three-year follow-up and patient-reported outcomes from CheckMate 078: Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced non-small cell lung cancer

Journal article published in 2022 by Jianhua Chang, Yi-Long Wu, Shun Lu, Jie Wang, Tony Mok, Li Zhang, Jifeng Feng, Lin Wu, Hai-Yan Tu, Yiping Zhang, Alexander Luft, Jian-Ying Zhou, Zhiyong Ma, You Lu, Chengping Hu and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO